H. Guo

A Phase II Feasibility Study of Palbociclib in Combination with Adjuvant Endocrine Therapy for Hormone Receptor Positive Invasive Breast Carcinoma.

E. Winer, W. Barry, H. Rugo, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

11C-PD153035 PET/CT for molecular imaging of EGFR in patients with non-small cell lung cancer (NSCLC)

L. Kong, Shu-qiang Zhao, L. Ma, 2008 .

The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial.

E. Winer, W. Barry, D. Dillon, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Obesity and Cancer Treatment Outcomes: Interpreting the Complex Evidence.

A. Renehan, J. Barriuso, Huiyue Guo, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma.

E. Winer, W. Barry, H. Rugo, 2019 .

A meta-analysis of bevacizumab combined with chemotherapy in the treatment of ovarian cancer.

W. Lei, P. Wen, Y. Yang, 2014, Indian journal of cancer.

Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in non-small cell lung cancer.

J. Li, X. Sun, J. Yu, 2006, Journal of Clinical Oncology.

119P A pan-cancer study on difference of homologous recombination deficiency and tumour mutational burden between Chinese and Western patients

H. Guo, T. Guo, L. Yan, 2020 .